The research conducted by the Shafiee group revealed that genistein possesses the capability to reduce MMP-2 expression across a spectrum of human prostate cancer cell lines, spanning from primary noncancerous cells to well-established metastatic variants [156]. The gene discussed is MMP2; the disease is prostate carcinoma.